Champion Iron Limited (TSX:CIA)

Theseus Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	176.05	117.45	400.06	326.81	321.89	609.32
Cash & Short-Term Investments	176.05	117.45	400.06	326.81	321.89	609.32
Cash Growth	-32.25%	-70.64%	22.41%	1.53%	-47.17%	116.56%
Accounts Receivable	67.7	145.46	71.56	131.79	93.53	73.34
Other Receivables	62.71	60.19	48.52	68.39	30.61	25.41
Receivables	130.4	205.64	120.08	200.18	124.14	98.76
Inventory	310.52	357.49	332.61	167.67	98.86	66.81
Prepaid Expenses	28.16	20.97	25.14	22.99	12.5	5.45
Other Current Assets	26.7	30.76	22.23	20.37	38.55	27.2
Total Current Assets	671.84	732.31	900.12	738.02	595.94	807.54
Property, Plant & Equipment	2,286	2,194	1,678	1,379	1,178	581.09
Long-Term Investments	14.61	15.39	14.51	11.78	11.41	9.7
Other Intangible Assets	4.98	5.22	5.17	7.87	8.55	6.26
Long-Term Deferred Charges	-	5.69	7.83	8.6	-	-
Other Long-Term Assets	83.09	77.16	84.13	169.91	195.49	92.32
Total Assets	3,060	3,030	2,690	2,315	1,989	1,497
Accounts Payable	186.38	232.94	203.03	135.32	160.1	83.4
Accrued Expenses	30.3	58.08	59.15	29.85	34.55	104.94
Current Portion of Long-Term Debt	56.27	40.73	31.06	27.08	72	-
Current Portion of Leases	20.06	13.72	6.33	13.41	2.29	0.5
Current Income Taxes Payable	15.24	10.81	23.51	-	17.79	104.94
Other Current Liabilities	58.48	2.4	-	-	0.18	-
Total Current Liabilities	366.73	358.68	323.07	205.66	286.89	293.77
Long-Term Debt	687.17	666.58	508.37	448.2	251.37	214.95
Long-Term Leases	86.96	78.62	70.65	73.43	51.69	1.4
Long-Term Unearned Revenue	8.27	8.57	9.8	10.61	8.73	-
Long-Term Deferred Tax Liabilities	317.13	325.11	281.14	215.73	124.99	84.53
Other Long-Term Liabilities	151.33	157.25	100.02	98.94	103.87	49.24
Total Liabilities	1,618	1,595	1,293	1,053	827.53	643.89
Common Stock	470.09	411.05	409.79	401.28	398.64	356.46
Additional Paid-In Capital	16.65	16.65	17.37	22.8	21.34	22.31
Retained Earnings	955.5	985.04	946.64	815.91	718.71	284.24
Comprehensive Income & Other	0.42	22.66	22.72	22.72	23.01	30.5
Total Common Equity	1,443	1,435	1,397	1,263	1,162	693.51
Shareholders' Equity	1,443	1,435	1,397	1,263	1,162	853.02
Total Liabilities & Equity	3,060	3,030	2,690	2,315	1,989	1,497
Total Debt	850.47	799.64	616.41	562.12	377.34	216.85
Net Cash (Debt)	-674.41	-682.19	-216.35	-235.32	-55.45	392.46
Net Cash Growth	-	-	-	-	-	15567.19%
Net Cash Per Share	-1.28	-1.29	-0.41	-0.45	-0.11	0.78
Filing Date Shares Outstanding	533.25	518.25	518.07	517.19	516.61	506.32
Total Common Shares Outstanding	533.25	518.25	518.07	517.19	516.61	502.12
Working Capital	305.11	373.62	577.05	532.36	309.05	513.77
Book Value Per Share	2.71	2.77	2.70	2.44	2.25	1.38
Tangible Book Value	1,438	1,430	1,391	1,255	1,153	687.25
Tangible Book Value Per Share	2.70	2.76	2.69	2.43	2.23	1.37
Machinery	1,133	1,106	945.4	890.62	277.39	216.12
Construction In Progress	428.36	365.88	153.51	29.26	531.79	176.08

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.